ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626676 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626676; 2) Community: the network communities that were significantly associated with the response to NSC 626676; 3) Molecule: the relationships between components within communities and NSC 626676; 4) MDR: the compounds that were significantly associated with the NSC 626676.

NSC Compound Enrichment Correlation
NSC 702208 Spiro[benzo[1,2-b:5,4-c']dipyran-2(3H),2'(3'H)-naphtho[2,3- b]furan]-7-carboxylic acid, 3'-[(2,6-dideoxy-3-O-methylhexo pyranosyl)oxy]-4,5',8',9-tetrahydro-3,4',9',10-tetrahydroxy-7'-methoxy-5',8',9- 0.0018088833864761 -0.01604211
NSC 709520 Null 0.0018088833864761 0.30307127
NSC 710099 Null 0.0018088833864761 0.39928815
NSC 741078 Selumetinib 0.0018088833864761 0.072628088
NSC 321239 Mercury, (2-hydroxy-5-nitrophenyl)(6-thioguanosinato-N(7),S(6))- 0.00180888338647612 0.34016821
NSC 48229 Null 0.00180888338647612 -0.28711321
NSC 628572 Null 0.00189155427362373 0.64927919
NSC 649150 Null 0.00189155427362373 0.37697195
NSC 658387 6,9-Ethanobenzo[g]quinoxaline-5,10-diol, 6,9-dihydro- 2,3-dimethyl- 0.00189155427362373 0.52058047
NSC 681684 2-Trifluoroethoxy-6-oxoestra-1,3,5(10)-trien-3,17.beta.-diol 0.00189155427362373 0.33234713
Total:104  Current:14    [First] [Prev] [Next] [Last]